113082-27-2 Usage
General Description
2-chloro-6-fluoroquinazoline is a chemical compound with the formula C9H5ClFN2. It is a quinazoline derivative bearing a chlorine atom at the 2-position and a fluorine atom at the 6-position. 2-chloro-6-fluoroquinazoline is used as a building block in the synthesis of various pharmaceuticals and agrochemicals. Its structure and properties make it a useful intermediate in organic chemistry, particularly in the development of new drugs and pesticides. Additionally, its ability to form various derivatives and analogs makes it a valuable tool for medicinal and chemical research.
Check Digit Verification of cas no
The CAS Registry Mumber 113082-27-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,3,0,8 and 2 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 113082-27:
(8*1)+(7*1)+(6*3)+(5*0)+(4*8)+(3*2)+(2*2)+(1*7)=82
82 % 10 = 2
So 113082-27-2 is a valid CAS Registry Number.
InChI:InChI=1/C8H4ClFN2/c9-8-11-4-5-3-6(10)1-2-7(5)12-8/h1-4H
113082-27-2Relevant articles and documents
INHIBITORS OF CYCLIN-DEPENDENT KINASES
-
, (2019/11/19)
Provided herein are inhibitors of cyclin-dependent kinases (CDKs), pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.
OCTAHYDROPYRROLO [3, 4-c] PYRROLE DERIVATIVES AND USES THEREOF
-
, (2017/07/04)
The invention relates to octahydropyrrolo [3, 4-c] pyrrole derivatives and uses thereof. Compounds and pharmaceutical compositions comprising the compounds provided herein are used for antagonizing orexin receptors. The invention also relates to processes for preparing the compounds and pharmaceutical compositions, and uses thereof in treating or preventing a disease related to orexin receptors.
NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN
-
Page/Page column 320, (2014/10/18)
The present invention relates to compounds and composition for inhibition of FASN, their synthesis, applications, and antidotes. An illustrative compound of the invention is shown below: